NCT04292405

Brief Summary

Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2020

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 28, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 3, 2020

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

October 30, 2025

Status Verified

October 1, 2025

Enrollment Period

5.7 years

First QC Date

February 28, 2020

Last Update Submit

October 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • CABs comparison

    Simultaneous CABs recordings from the AUDICOR and WCD devices will be compared

    2 hours

Study Arms (1)

Heart Failure Patients

Simultaneous recordings of cardiac acoustic biomarkers (CABs) by the Wearable Cardioverter Defibrillator and the AUDICOR AM

Device: Wearable Cardioverter Defibrillator

Interventions

Use of the Wearable Cardioverter Defibrillator and AUDICOR AM to evaluate accuracy of cardiac acoustic biomarker recordings.

Also known as: AUDICOR AM
Heart Failure Patients

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary Care, Heart Failure, and Cardiology

You may qualify if:

  • years of age or older
  • heart failure or a history of heart failure
  • ischemic or non-ischemic cardiomyopathy
  • ejection Fraction less than or equal to 40% as measured within the last 6 months

You may not qualify if:

  • implanted left ventricular assist device
  • pacemaker dependency
  • currently hospitalized
  • atrial fibrillation on their last ECG or having an irregularly irregular pulse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MAYO Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Mike Osz

    Director, Clinical Operations, ZOLL

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2020

First Posted

March 3, 2020

Study Start

January 23, 2020

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

October 30, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations